INS and Hyperglycemia: We observed that Pdx1tTA/+ mice exhibit previously reported MODY4 symptoms including hyperglycemia, reduced plasma insulin, impaired glucose tolerance, and aberrant localization of alpha cells to the core of the islet (Figure 7C–P).